Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: Application of the methylation cassette assay to the Epstein-Barr virus major latency promoter

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6445-6454

  Robertson, Keith D ^a,c   Ambinder, Richard F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; DNA METHYLATION; ENHANCER REGION; EPSTEIN BARR VIRUS; HODGKIN DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS LATENCY; VIRUS TRANSCRIPTION;

BINDING SITES; CHROMOSOME MAPPING; DNA METHYLATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030860852     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Chen, F., J.-Z. Zou, L. D. Renzo, G. Winberg, K.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1. J. Virol. 69:3752-3758.
2. Du, Z., D. A. Regier, and R. C. Desrosiers. 1995. Improved recomhinant PCR mutagenesis procedure that uses alkaline-denatured plasmid template. BioTechniques 18:376-377.
3. Evans, T. J., P. J. Farrell. and S. Swamlnathan. 1996. Molecular genetic analysis of Epstein-Barr virus Cp promoter function. J. Virol. 70:1695-1705.
4. Evans, T. J., M. G. Jacquemin, and P. J. Farrell. 1995. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle. Virology 206:806-877.
5. Frommer, M., L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89:1827-1831.
6. Gerber-Huber, S., F. E. B. May, B. K. Westley, B. K. Felber, H. A. Hoshach, A.-C. Andres, and G. U. Ryffel. 1983. In contrast to other Xenopus genes. the estrogen-inducible vitellogenin genes are expressed when totally methylated. Cell 33:43-51.
7. Gotz, F., K. Schulze-Konter, H. Wagner, H. Kroger, and D. Simon. 1990. Transcription inhibition of SV40 by in vitro DNA methylation. Biochim. Biophys. Acta 1087:323-329.
8. Graessmann, M., A. Graessmann, H. Wagner, E. Werner, and D. Simon. 1983. Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expression. Proc. Natl. Acad. Sci. USA 80:6470-6474.
9. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivntor is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7508-7572.
10. Hasse, A., and W. A. Schulz. 1994. Enhancement of reporter gene de novo methylation by DNA fragments from the α-fetoprotein control region. J. Biol. Chem. 269:1821-1826.
11. K. Science 265:92-95.
12. Jahner, D., H. Stuhlmann, C. L. Stewart, K. Harbers, J. Lohler, I. Simon, and R. Jaenisch. 1982. De novo methylation and expression of retroviral genomes during mouse embryogencsis. Nature 298:623-628.
13. Kass, S. U., J. P. Goddard, and R. L. P. Adams. 1993. Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13:7372-7379.
14. Keshet, I., J. Yisraeli, and H. Cedar. 1985. Effect of regional DNA methylation on gene expression. Proc. Natl. Acad. Sci. USA 82:2560-2564.
15. k interact with an Epstcin-Barr virus nuclear antigen 2 responsive cis-element. EMBO J. 13:5624-5632.
16. Levine, A., G. L. Cantoni, and A. Razin. 1092. Methylation in the preinitiation domain suppresses gene transcription by an indirect mechanism. Proc. Natl. Acad. Sci. USA 89:10119-10123.
17. Liebowitz, D., and E. Kieff'. 1993. Epstein-Barr virus. p. 107-172. In B. Roizman. R. J. Whilley, C. Lopez (ed.), The human herpesviruses. Raven Press, New York, N.Y.
18. Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The EBV immortalizing protein EBNA-2 is targeted to DNA by a cellular cnhancer-bindinu protein. Proc. Natl. Acad. Sci. USA 90:9237-9241.
19. Magewu, A. N., and P. A. Jones. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 14:4225-4232
20. Masucci, M. G., B. Contreras-Salazar, E. Ragner, K. Falk, J. Minarovits,I. Ernberg, and G. Klein. 1989. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael. J. Virol. 63:3135-3141.
21. Mummaneni, P., K. A. Walker, P. L. Bishop, and M. S. Turker. 1995 Epigenetic gene inactivation induced by a cis-acting methylation center J. Biol. Chem. 270:788-792. |
22. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. I992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Burr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157-168.
23. Nilsson, T., A. Sjoblom, M. G. Masucci, and L. Rymo. 1993. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotypes. Virology 193:774-785.
24. Orend, G., M. Knoblauch, C. Kammer. S. T. Tjia, B. Schmitz, A. Linkwitz, G. M. zu Altenschildesche, J. Maas, and W. Doerfier. 1995. The initiation of de novo methylation of foreign DNA integrated into a mammalian genome is not exclusively targeted by nucleotide sequence. J. Virol. 69:1226-1242.
25. Orend, G., I. Kuhlmann, and W. Doerfler. 1991. Spreading of DNA methylation across integrated foreign (adenovirus type 12) genomes in mammalian cells. J. Virol. 65:4301-4308.
26. Paroush, Z., I. Keshet, J. Yisraeli, and H. Cedar. 1990. Dynamics of de-mcthylation and activation of the α-actin gene in myohlasts. Cell 63:1229-1237.
27. Puglielli, M. T., M. Woisetschlaeger, and S. M. Speck. 1996, P is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J. Virol. 70:5758-5768.
28. Qu, L., and D. T. Rowe. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:3715-3724.
29. Rawlins, D. R., G. Milman, S.D. Hayward, G. S. Hayward. 1985, Sequence- specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
30. Reisman, D., and B. Sugden. 1986. trans Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
31. Robertson, E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, B. Tomkison, and E. Kieff. 1995. Epstein-Barr virus nuclear protein 3C modulats transcription through interaction with the sequence-specific DNA-binding protein JK. J. Virol. 69:3108-3116.
32. Robertson, K. D., J. Barletta, D. Samid, and R. F. Ambinder, 1994. Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr virus associated malignancies. Curr. Top. Microbiol. Immunol. 194:145-154.
33. Robertson, K. D., S. D. Hayward, P. D. Ling, D. Sumid, and R. F. Ambinder, 1995. Transcriptional activation of the Epstein-Barr virus latency C promoter alter 5-azacytidine treatment: evidence that dumethylation at a single CpG site is crucial. Mol. Cell. Biol. 15:6150-6159.
34. Robertson, K. D., A. Manns, L. J. Swinnen, J. C. Zong, M. L. Gulley, and R. F. Ambinder. 1996. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Blood 88: 3129-3136.
35. Robertson, K.D., and R. F. Ambinder. Methylation of the Epstein-Barr virus genome in normal lymphocytes. Submitted for publication.
36. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne, 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
37. Sugden, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:2644-2649.
38. Swaminathan, S. 1996. Characterization of Epstein-Barr virus reeombinants with deletions of the Bam HI C promoter. Virology 217:532-541.
39. Tlerney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstcin-Burr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
40. Waltzer, L., F. Logeat, C. Brou, A. Israel, A. Sergeant, and E. Manet. 1994. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus LL3NA2 protein to its DNA responsive elements. EMBO J. 13:5663-5638.
41. Waltzer, L., M. Pcrricaudet. A. Sergeant, and E. Manet. 1996. Einstein-Barr virus EBNA-3A and EBNA-3C proteins both repress RBP-JK-EBNA2-activated transcription by inhibiting the binding of RBP-JK to DNA, J. Virol. 70:5909-5915.